Gerald Schulman

Pediatrics
1360 Ocean Pkwy Apt 1E
Brooklyn, NY 11230

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Journal: Clinical and experimental nephrology
Published: March 25, 2016

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Journal: BMC nephrology
Published: January 21, 2016

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Journal: Journal of the American Society of Nephrology : JASN
Published: July 26, 2014

AST-120 for the management of progression of chronic kidney disease.

AST-120 for the management of progression of chronic kidney disease.

Journal: International journal of nephrology and renovascular disease
Published: February 07, 2014

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 10, 2014

Hemodialysis: core curriculum 2014.

Hemodialysis: core curriculum 2014.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: May 01, 2013

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: July 24, 2012

In-center thrombolysis for clotted AV access: a cohort review.

In-center thrombolysis for clotted AV access: a cohort review.

Journal: Seminars in dialysis
Published: July 13, 2012

Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.

Journal: Journal of the American Society of Nephrology : JASN
Published: February 25, 2012

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis
Published: February 07, 2012

Novel dialysis modalities: do we need new metrics to optimize treatment?

Novel dialysis modalities: do we need new metrics to optimize treatment?

Journal: Journal of clinical pharmacology
Published: January 11, 2012

A nexus of progression of chronic kidney disease: tryptophan, profibrotic cytokines, and charcoal.

A nexus of progression of chronic kidney disease: tryptophan, profibrotic cytokines, and charcoal.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
Published: October 11, 2011
Showing 1-12 of 14

Last Updated: 09/26/2026